2024-08-01 2025-07-31 false Capium Accounts Production 1.1 12120028 2024-08-01 2025-07-31 12120028 bus:AbridgedAccounts 2024-08-01 2025-07-31 12120028 bus:FRS102 2024-08-01 2025-07-31 12120028 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 12120028 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 12120028 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12120028 2024-08-01 2025-07-31 12120028 2025-07-31 12120028 bus:RegisteredOffice 2024-08-01 2025-07-31 12120028 core:WithinOneYear 2025-07-31 12120028 core:AfterOneYear 2025-07-31 12120028 1 2024-08-01 2025-07-31 12120028 bus:Director1 2024-08-01 2025-07-31 12120028 bus:Director1 2025-07-31 12120028 bus:Director1 2023-08-01 2024-07-31 12120028 bus:Director2 2024-08-01 2025-07-31 12120028 bus:Director2 2025-07-31 12120028 bus:Director2 2023-08-01 2024-07-31 12120028 2023-08-01 12120028 bus:LeadAgentIfApplicable 2024-08-01 2025-07-31 12120028 2023-08-01 2024-07-31 12120028 2024-07-31 12120028 core:WithinOneYear 2024-07-31 12120028 core:AfterOneYear 2024-07-31 12120028 bus:EntityAccountantsOrAuditors 2023-08-01 2024-07-31 12120028 core:MotorCars 2024-08-01 2025-07-31 12120028 core:MotorCars 2025-07-31 12120028 core:MotorCars 2024-07-31 12120028 core:FurnitureFittings 2024-08-01 2025-07-31 12120028 core:FurnitureFittings 2025-07-31 12120028 core:FurnitureFittings 2024-07-31 12120028 core:ComputerEquipment 2024-08-01 2025-07-31 12120028 core:ComputerEquipment 2025-07-31 12120028 core:ComputerEquipment 2024-07-31 12120028 core:PlantMachinery 2024-08-01 2025-07-31 12120028 core:PlantMachinery 2025-07-31 12120028 core:PlantMachinery 2024-07-31 12120028 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-07-31 12120028 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 12120028 core:NetGoodwill 2024-08-01 2025-07-31 12120028 core:NetGoodwill 2025-07-31 12120028 core:NetGoodwill 2024-07-31 12120028 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 12120028 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 12120028 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 12120028 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12120028 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12120028 core:Non-currentFinancialInstruments 2025-07-31 12120028 core:Non-currentFinancialInstruments 2024-07-31 12120028 core:ShareCapital 2025-07-31 12120028 core:ShareCapital 2024-07-31 12120028 core:RetainedEarningsAccumulatedLosses 2025-07-31 12120028 core:RetainedEarningsAccumulatedLosses 2024-07-31 12120028 dpl:Item1 2024-08-01 12120028 dpl:Item1 2025-07-31 12120028 dpl:Item1 2023-08-01 12120028 dpl:Item1 2024-07-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12120028
England and Wales
AS PHARMA SERVICES LTD
Abridged Accounts
Period of accounts Start date: 01 August 2024 End date: 31 July 2025

AS PHARMA SERVICES LTD Contents Page For the year ended 31 July 2025
Accountants' Report | 1
Statement of Financial Position | 2
Notes to the Financial Statements | 3

AS PHARMA SERVICES LTD Accountants' Report For the year ended 31 July 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 July 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Brookwater Accountants Ltd 31 July 2025 .................................................... Brookwater Accountants Ltd Devere House 62 Vicar Lane Bradford BD1 5AH 16 March 2026 1

AS PHARMA SERVICES LTD Statement of Financial Position As at 31 July 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 202,500 |  | 243,000
Tangible fixed assets | 4 | 127,055 |  | 27,813
|  | 329,555 |  | 270,813
Current assets |  |  |
Stocks |  | 28,105 |  | 23,957
Debtors |  | 158,160 |  | 116,642
Cash at bank and in hand |  | 138,649 |  | 78,283
|  | 324,914 |  | 218,882
Creditors: amount falling due within one year |  | (225,252) |  | (127,717)
Net current assets |  | 99,662 |  | 91,165
Total assets less current liabilities |  | 429,217 |  | 361,978
Creditors: amount falling due after more than one year |  | (383,147) |  | (382,855)
Provisions for liabilities |  | (31,510) |  | (4,593)
Net assets |  | 14,560 |  | (25,470)
Capital and reserves |  |  |
Called up share capital |  | 100 |  | 100
Profit and loss account |  | 14,460 |  | (25,570)
Shareholders' funds |  | 14,560 |  | (25,470)
For the year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 16 March 2026 and were signed on its behalf by:
------------------------------- Adnaan Omar AHMED Director
2

AS PHARMA SERVICES LTD Notes to the Abridged Financial Statements For the year ended 31 July 2025
General Information AS PHARMA SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 12120028, registration address Silsden Pharmacy 76 78 Kirkgate, Silsden, Keighley, West Yorkshire, BD20 0PA. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Deferred taxation Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Current and deferred tax assets and liabilities are not discounted. Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 10 years. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and machinery etc | 20%
Assets on finance lease and hire purchase Assets held under finance lease or hire purchase contracts i.e. those contracts where substantially all the risks and rewards of ownership have passed to the company, are included in the appropriate category of tangible fixed assets and depreciated over the shorter of the lease term and their estimated expected useful lives. Future obligations under such contracts are included in creditors net of the finance charge allocated to future periods. Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Provisions Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2. | Average number of employees Average number of employees during the year was 9 (2024 : 6).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 August 2024 | 405,000 |  | 405,000
Additions | - |  | -
Disposals | - |  | -
At 31 July 2025 | 405,000 |  | 405,000
Amortisation
At 01 August 2024 | 162,000 |  | 162,000
Charge for year | 40,500 |  | 40,500
On disposals | - |  | -
At 31 July 2025 | 202,500 |  | 202,500
Net book values
At 31 July 2025 | 202,500 |  | 202,500
At 31 July 2024 | 243,000 |  | 243,000
4. | Tangible fixed assets
Cost or valuation | Plant and machinery etc |  | Total
| £ |  | £
At 01 August 2024 | 44,814 |  | 44,814
Additions | 107,673 |  | 107,673
Disposals | - |  | -
At 31 July 2025 | 152,487 |  | 152,487
Depreciation
At 01 August 2024 | 17,001 |  | 17,001
Charge for year | 8,431 |  | 8,431
On disposals | - |  | -
At 31 July 2025 | 25,432 |  | 25,432
Net book values
Closing balance as at 31 July 2025 | 127,055 |  | 127,055
Opening balance as at 01 August 2024 | 27,813 |  | 27,813
The net book value of Plant and machinery etc includes £ 93,334 in respect of assets leased under finance leases or hire purchase contracts.
3